This significant increase in holdings suggests a positive outlook on Colgate-Palmolive’s future prospects. It also indicates that Hazlett Burt & Watson Inc. is confident in the company’s ability to generate strong returns for its investors.
Analysts at Evercore ISI also commented on Colgate, stating that the company is well-positioned for growth in the oral care market. Analysts at Morgan Stanley have also expressed their positive outlook on Colgate, highlighting its strong brand portfolio and its ability to leverage its global reach. **Key Takeaways:**
* **Positive Analyst Sentiment:** Wall Street analysts are overwhelmingly positive about Colgate-Palmolive’s future prospects.
The company’s financial performance has been strong, with revenue growth of 1.4% year-over-year and net income growth of 1.7% year-over-year. This performance is attributed to the company’s focus on innovation and its ability to adapt to changing consumer preferences. Colgate-Palmolive’s competitive landscape is dominated by Procter & Gamble, Unilever, and Johnson & Johnson.
Colgate-Palmolive Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.50 per share. The ex-dividend date was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.87%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%. Insider Activity In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Gregory Malcolm sold 10,533 shares of the firm’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,490 shares of company stock valued at $4,486,063. Company insiders own 0.34% of the company’s stock.
The company’s portfolio includes a wide range of oral care products, including toothpastes, mouthwashes, and toothbrushes. Colgate-Palmolive is a global leader in the oral care industry, with a strong presence in over 200 countries. The company’s history dates back to 1806, when William Colgate founded the company in New York City.
news is a contributor at Roll Pet. We are committed to providing well-researched, accurate, and valuable content to our readers.
